¼¼°èÀÇ ÀÌ Ä¡·á ½ÃÀå - Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼ : À¯Çüº°, Ä¡·áº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)
Lice Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Pediculosis Capitis, Pediculosis Corporis, and Pediculosis Pubis); By Treatment; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
»óǰÄÚµå
:
1463136
¸®¼Ä¡»ç
:
Polaris Market Research
¹ßÇàÀÏ
:
2024³â 03¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 114 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ÀÌ Ä¡·á ¼¼°è ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 16¾ï 8,472¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ¼³¹®Á¶»ç º¸°í¼´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» ÀÚ¼¼È÷ ÆÄ¾ÇÇϰí ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.
¼¼°èÀÇ ÀÌÁ¾ ±â»ýÃæ ¿À¿°ÀÇ À¯º´·üÀÇ ´ëÆøÀûÀÎ Áõ°¡, È¿´ÉÀÇ °³¼±, »ç¿ëÇϱ⠽¬¿î µµÆ÷ ¹æ¹ýÀÇ °³¹ß, »õ·Î¿î À¯È¿ ¼ººÐÀÇ ¹èÇÕ µî, Á¦Ç° ó¹æÀÇ ´ëÆøÀûÀÎ Áøº¸·Î À̾îÁö´Â ¿¬±¸ °³¹ß Ȱµ¿À̳ª ´ëó Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. °Ô´Ù°¡, ÀÌ °¨¿°°ú ÀÌ¿ë °¡´ÉÇÑ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̱â À§ÇØ, ÀÇ·á Á¶Á÷À̳ª ´ç±¹¿¡ ÀÇÇÑ °è¹ß Ä·ÆäÀÎÀ̳ª ±³À° ÇÁ·Î±×·¥ÀÇ º¸±ÞÀÌ ÁøÇàµÇ°í ÀÖ´Â °Íµµ, ½ÃÀå ¼ºÀå¿¡ Ç÷¯½ºÀÇ ¿µÇâÀ» ¹ÌÄ¥ °Í °°½À´Ï´Ù.
¿¹¸¦ µé¾î, 2023³â 8¿ù, Mediker´Â "Mediker On Juey Gonel"À̶ó´Â À̸§ÀÇ »õ·Î¿î Ä·ÆäÀÎÀÇ ½ÃÀÛÀ» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Ä·ÆäÀÎÀ» ÅëÇØ ÀüÅëÀûÀÎ À̰¡ ¹ö¼¸¸¸À¸·Î´Â À̸¦ È¿°úÀûÀ¸·Î Á¦°ÅÇÒ ¼ö ¾øÀ¸¸ç Ãß°¡ Ä¡·á°¡ ÇÊ¿äÇÔÀ» ¼ÒºñÀÚ¿¡°Ô °è¸ùÇÕ´Ï´Ù.
°Ô´Ù°¡, ÀÌ È®»êÀº ÀÌ ±â»ýÁõÀ¸·Îµµ ¾Ë·ÁÁ® ÀÖÀ¸¸ç ¼¼°è ¼ö¹é¸¸ ¸íÀÇ »ç¶÷µé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¡±â ¶§¹®¿¡ È¿°úÀûÀ̰í Çõ½ÅÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ ¿ä±¸°¡ Ä¿Áö°í ½ÃÀå ¹ßÀü·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ÃÖ±Ù ¸î ³â°£ ½ÃÀåÀº LED ¶óÀÌÆ®¿Í ¸¶ÀÌÅ©·ÎÇÁ·Î¼¼¼¸¦ žÀçÇÑ Çõ½ÅÀûÀÎ ºøÇü ±â±¸ °³¹ß µî ±â¼úÀû Áøº¸ ¸é¿¡¼ Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù.
»ìÃæÁ¦ ³»¼ºÀ̳ª ÈÇй°Áú¿¡ÀÇ ³ëÃâ¿¡ ´ëÇÑ ¿ì·Á°¡ ³ô¾ÆÁö´Â °¡¿îµ¥, õ¿¬ ¼ººÐÀ̳ª ¹«ÇØÇÑ ¼ººÐÀ» ¿ä±¸ÇÏ´Â ¼ÒºñÀÚÀÇ ±âÈ£¸¦ ÃæÁ·½ÃŰ´Â ±â´ÉÀ» °®Ãá, º¸´Ù È¿°úÀûÀÎ ÀÌ ±¸Á¦¿ë ½ÅÁ¦Ç°À» °³¹ßÇÏ´Â Å« ±âȸ°¡ ±â¾÷ ¿¡ Á¸ÀçÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 11¿ù, Torque Pharma´Â Torque Kvach ÆÛ½º³ÎÄÉ¾î ºê·£µåÀÇ ÀÏȯÀ¸·Î »õ·Î¿î ÀÌ Á¦°Å Å©¸² ¿ö½ÃÀÇ Ãâ½Ã¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ »õ·Î¿î Ãâ½Ã Á¦Ç°Àº õ¿¬ ¼ººÐÀÇ ÀÌÁ¡À» Ȱ¿ëÇÏ¿© ¸Ó¸®Ä«¶ôÀ» ¼Õ»ó½ÃŰÁö ¾Ê°í È¿°úÀûÀ¸·Î À̸¦ Á¦°ÅÇÕ´Ï´Ù.
ÀÌ Ä¡·á ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
¸Ó¸´´Ï ÁõÀº ¸Ó¸´´Ï ¹ßº´·ü Áõ°¡¿Í Á¶±â ¹ß°ßÀÇ Á߿伺¿¡ ´ëÇÑ ÀνĿ¡¼ ¶Ñ·ÇÇÑ Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù.
ÆíÀǼº ¹× ºñ¿ë È¿°ú¿Í °°Àº ÀÌÁ¡À¸·Î ÀÎÇØ OTC Á¦Ç° ºÎ¹®ÀÌ ´ëºÎºÐÀÇ Á¡À¯À²À» Â÷Áö
º´¿ø¿¡¼ Ä¡·á¹Þ´Â ȯÀÚ Áõ°¡¿Í 󹿾àÀÇ ÀÔ¼ö°¡ ¿ëÀÌÇϱ⠶§¹®¿¡ º´¿ø ¾à±¹ ºÎ¹®ÀÌ °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
ºÏ¹Ì´Â °Ç° °ü¸® ÀÎÇÁ¶ó°¡ Á¤ºñµÇ¾î ¼ÒºñÀÚÀÇ °¡Ã³ºÐ ¼ÒµæÀÌ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ ¼¼°è ½ÃÀåÀ» ¼®±Ç
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Á¶»ç ¹æ¹ý
Á¦4Àå ¼¼°èÀÇ ÀÌ Ä¡·á ½ÃÀå ÀλçÀÌÆ®
ÀÌ Ä¡·á ½ÃÀå - À¯Åë ä³Î ½º³À¼¦
ÀÌ Ä¡·á ½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀΰú ±âȸ
¶óÀÌÇÁ ½ºÅ¸Àϰú À§»ý ½À°üÀÇ º¯È°¡ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼Ó
±ÔÁ¦ ´ç±¹¿¡ ÀÇÇÑ Á¦Ç° ½ÂÀÎ Áõ°¡
¾ïÁ¦¿äÀΰú °úÁ¦
Ä¡·áºñÀÇ ³ôÀÌ¿Í ÀÎÁöµµÀÇ ³·À½
PESTEL ºÐ¼®
ÀÌ Ä¡·á ½ÃÀåÀÇ À¯Åë ä³ÎÀÇ µ¿Çâ
¹ë·ùüÀÎ ºÐ¼®
COVID-19ÀÇ ¿µÇ⠺м®
Á¦5Àå ¼¼°èÀÇ ÀÌ Ä¡·á ½ÃÀå, À¯Çüº°
ÁÖ¿ä Á¶»ç °á°ú
¼Ò°³
¸Ó¸®À̱â»ýÁõ
¸öÀ̱â»ýÁõ
»ç¸é¹ßÀ̱â»ýÁõ
Á¦6Àå ¼¼°èÀÇ ÀÌ Ä¡·á ½ÃÀå, Ä¡·áº°
ÁÖ¿ä Á¶»ç °á°ú
¼Ò°³
OTC Á¦Ç°
󹿾à
±âŸ
Á¦7Àå ¼¼°èÀÇ ÀÌ Ä¡·á ½ÃÀå, À¯Åë ä³Îº°
ÁÖ¿ä Á¶»ç °á°ú
¼Ò°³
º´¿ø ¹× Áø·á¼Ò
¼Ò¸Å ¾à±¹
¿Â¶óÀÎ Ç÷§Æû
±âŸ
Á¦8Àå ¼¼°èÀÇ ÀÌ Ä¡·á ½ÃÀå, Áö¿ªº°
ÁÖ¿ä Á¶»ç °á°ú
¼Ò°³
ÀÌ Ä¡·á ½ÃÀå Æò°¡, Áö¿ªº°(2019-2032³â)
ÀÌ Ä¡·á ½ÃÀå - ºÏ¹Ì
ºÏ¹Ì : ÀÌ Ä¡·á ½ÃÀå, À¯Çüº°(2019-2032³â)
ºÏ¹Ì : ÀÌ Ä¡·á ½ÃÀå, À¯Åë ä³Îº°(2019-2032³â)
ºÏ¹Ì : ÀÌ Ä¡·á ½ÃÀå, Ä¡·áº°(2019-2032³â)
ÀÌ Ä¡·á ½ÃÀå - ¹Ì±¹
ÀÌ Ä¡·á ½ÃÀå - ij³ª´Ù
ÀÌ Ä¡·á ½ÃÀå - À¯·´
À¯·´ : ÀÌ Ä¡·á ½ÃÀå, À¯Çüº°(2019-2032³â)
À¯·´ : ÀÌ Ä¡·á ½ÃÀå, À¯Åë ä³Îº°(2019-2032³â)
À¯·´ : ÀÌ Ä¡·á ½ÃÀå, Ä¡·áº°(2019-2032³â)
ÀÌ Ä¡·á ½ÃÀå - ¿µ±¹
ÀÌ Ä¡·á ½ÃÀå - ÇÁ¶û½º
ÀÌ Ä¡·á ½ÃÀå - µ¶ÀÏ
ÀÌ Ä¡·á ½ÃÀå - ÀÌÅ»¸®¾Æ
ÀÌ Ä¡·á ½ÃÀå - ½ºÆäÀÎ
ÀÌ Ä¡·á ½ÃÀå - ³×´ú¶õµå
ÀÌ Ä¡·á ½ÃÀå - ·¯½Ã¾Æ
ÀÌ Ä¡·á ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
¾Æ½Ã¾ÆÅÂÆò¾ç : ÀÌ Ä¡·á ½ÃÀå, À¯Çüº°(2019-2032³â)
¾Æ½Ã¾ÆÅÂÆò¾ç : ÀÌ Ä¡·á ½ÃÀå, À¯Åë ä³Îº°(2019-2032³â)
¾Æ½Ã¾ÆÅÂÆò¾ç : ÀÌ Ä¡·á ½ÃÀå, Ä¡·áº°(2019-2032³â)
ÀÌ Ä¡·á ½ÃÀå - Áß±¹
ÀÌ Ä¡·á ½ÃÀå - Àεµ
ÀÌ Ä¡·á ½ÃÀå - ¸»·¹À̽þÆ
ÀÌ Ä¡·á ½ÃÀå - ÀϺ»
ÀÌ Ä¡·á ½ÃÀå - Àεµ³×½Ã¾Æ
ÀÌ Ä¡·á ½ÃÀå - Çѱ¹
ÀÌ Ä¡·á ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÀÌ Ä¡·á ½ÃÀå, À¯Çüº°(2019-2032³â)
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÀÌ Ä¡·á ½ÃÀå, À¯Åë ä³Îº°(2019-2032³â)
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : À̰¡½º Ä¡·á ½ÃÀå, Ä¡·áº°(2019-2032³â)
ÀÌ Ä¡·á ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
ÀÌ Ä¡·á ½ÃÀå - UAE
ÀÌ Ä¡·á ½ÃÀå - À̽º¶ó¿¤
ÀÌ Ä¡·á ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
ÀÌ Ä¡·á ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
¶óƾ¾Æ¸Þ¸®Ä« : ÀÌ Ä¡·á ½ÃÀå, À¯Çüº°(2019-2032³â)
¶óƾ¾Æ¸Þ¸®Ä« : À̰¡½º Ä¡·á ½ÃÀå, À¯Åë ä³Îº°(2019-2032³â)
¶óƾ¾Æ¸Þ¸®Ä« : ÀÌ Ä¡·á ½ÃÀå, Ä¡·áº°(2019-2032³â)
ÀÌ Ä¡·á ½ÃÀå - ¸ß½ÃÄÚ
ÀÌ Ä¡·á ½ÃÀå - ºê¶óÁú
ÀÌ Ä¡·á ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª
Á¦9Àå °æÀï ±¸µµ
È®´ë ¹× Àμö ºÐ¼®
ÆÄÆ®³Ê½Ê/Çù¾÷/°è¾à/°ø°³
Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ
Arbor Pharmaceuticals LLC(US)
Bayer AG(Germany)
Insight Pharmaceuticals(US)
Omega Pharma NV(Belgium)
Parasol Laboratories(US)
Pfizer Inc.(US)
Prestige Brands Holding Inc.(US)
Sanofi SA(France)
Sumitomo Chemical Co. Ltd.(Japan)
TAA Industries(Australia)
TecLabs Inc.(US)
Tyratech Inc.(US)
JHS
¿µ¹® ¸ñÂ÷
The global lice treatment market size is expected to reach USD 1,684.72 million by 2032, according to a new study by Polaris Market Research. The report "Lice Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Pediculosis Capitis, Pediculosis Corporis, and Pediculosis Pubis); By Treatment; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The substantial increase in the prevalence of lice parasites contamination worldwide and growing research & development activities or efforts leading to significant advancements in product formulations including improved efficacy, developing user-friendly application methods, and incorporating new active ingredients, are key factors driving the market growth. Additionally, rising proliferation for awareness campaigns and education programs by healthcare organizations and authorities to raise awareness about lice infestations and available treatment options, are further likely to have positive impact on market growth.
For instance, in August 2023, Mediker, announced the launch of its new campaign named "Mediker On Juey Gonel", that mainly aims at raising awareness about lice and its treatment options. Through this campaign, they will try to educate consumers that a conventional lice comb is not enough to effective remove lice and requires further treatments.
Furthermore, as lice infestations that is also knowns as pediculosis affect millions of people across the globe, thereby the growing need for effective and innovative treatments has led to evolution to the market. Over the last few years, the market has witnessed significant growth in terms of technological advancements such as development of innovative comb devices equipped with LED lights and microprocessors that are more effective in the detection and removing of lice from hair.
With the growing concerns about pesticide resistance and chemical exposure, there is significant opportunity for companies to develop new and more effective lice treatment products with capabilities to meet individual consumer preferences for natural and non-toxic ingredients. For instance, in November 2023, Torque Pharma, announced about the launch of its new Anti-Lice Cream Wash as a part of their Torque Kvach Personal Care Brand. The newly launched product has the benefits of natural ingredients to effective eliminate the lice without damaging or harming the hair because it contains blend of natural components like Reetha and Skikakai.
Lice Treatment Market Report Highlights
Pediculosis capitis segment accounted for notable share, on account of growing incidences of head lice and awareness about the importance of early detection
OTC products segment held the majority share, that is attributed to its benefits including convenience and cost-effectiveness
Hospital pharmacies segment will grow at fastest pace, due to rising number of patients undergoing treatments in hospitals and easy availability of prescription medications
North America dominated the global market, owing to region's well-established healthcare infrastructure and increased disposable income of consumers
The key market players include Insight Pharmaceuticals, Sumitomo Chemical, TecLabs, Omega Pharma, Bayer AG, and Arbor Pharmaceuticals
Polaris Market Research has segmented the lice treatment market report based on type, treatment, distribution channel, and region:
Lice Treatment, Type Outlook (Revenue - USD Million, 2023 - 2032)
Pediculosis Capitis
Pediculosis Corporis
Pediculosis Pubis
Lice Treatment, Treatment Outlook (Revenue - USD Million, 2023 - 2032)
OTC Products
Prescription Medications
Others
Lice Treatment, Distribution Channel Outlook (Revenue - USD Million, 2023 - 2032)
Hospitals and Clinics
Retail Pharmacies
Online Platform
Others
Lice Treatment, Regional Outlook (Revenue - USD Million, 2023 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
3. Research Methodology
3.1. Overview
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Lice Treatment Market Insights
4.1. Lice Treatment Market - Distribution Channel Snapshot
4.2. Lice Treatment Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Change in lifestyles and hygiene practices to drive market growth
4.2.1.2. Increasing number of product approvals by regulatory bodies
4.2.2. Restraints and Challenges
4.2.2.1. High cost of treatments and lack of awareness
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Lice Treatment Market Distribution Channel Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Lice Treatment Market, by Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Lice Treatment Market, by Type, 2019-2032 (USD Million)
5.3. Pediculosis Capitis
5.3.1. Global Lice Treatment Market, by Pediculosis Capitis, by Region, 2019-2032 (USD Million)
5.4. Pediculosis Corporis
5.4.1. Global Lice Treatment Market, by Pediculosis Corporis, by Region, 2019-2032 (USD Million)
5.5. Pediculosis Pubis
5.5.1. Global Lice Treatment Market, by Pediculosis Pubis, by Region, 2019-2032 (USD Million)
6. Global Lice Treatment Market, by Treatment
6.1. Key Findings
6.2. Introduction
6.2.1. Global Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
6.3. OTC Products
6.3.1. Global Lice Treatment Market, by OTC Products, by Region, 2019-2032 (USD Million)
6.4. Prescription Medications
6.4.1. Global Lice Treatment Market, by Prescription Medications, by Region, 2019-2032 (USD Million)
6.5. Others
6.5.1. Global Lice Treatment Market, by Others, by Region, 2019-2032 (USD Million)
7. Global Lice Treatment Market, by Distribution Channel
7.1. Key Findings
7.2. Introduction
7.2.1. Global Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
7.3. Hospitals and Clinics
7.3.1. Global Lice Treatment Market, by Hospitals and Clinics, By Region, 2019-2032 (USD Million)
7.4. Retail Pharmacies
7.4.1. Global Lice Treatment Market, by Retail Pharmacies, By Region, 2019-2032 (USD Million)
7.5. Online Platform
7.5.1. Global Lice Treatment Market, by Online Platform, By Region, 2019-2032 (USD Million)
7.6. Others
7.6.1. Global Lice Treatment Market, by Others, By Region, 2019-2032 (USD Million)
8. Global Lice Treatment Market, by Geography
8.1. Key findings
8.2. Introduction
8.2.1. Lice Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
8.3. Lice Treatment Market - North America
8.3.1. North America: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.3.2. North America: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.3.3. North America: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.3.4. Lice Treatment Market - U.S.
8.3.4.1. U.S.: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.3.4.2. U.S.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.3.4.3. U.S.: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.3.5. Lice Treatment Market - Canada
8.3.5.1. Canada: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.3.5.2. Canada.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.3.5.3. Canada: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.4. Lice Treatment Market - Europe
8.4.1. Europe: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.4.2. Europe.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.4.3. Europe: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.4.4. Lice Treatment Market - UK
8.4.4.1. UK: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.4.4.2. UK.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.4.4.3. UK: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.4.5. Lice Treatment Market - France
8.4.5.1. France: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.4.5.2. France.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.4.5.3. France: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.4.6. Lice Treatment Market - Germany
8.4.6.1. Germany: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.4.6.2. Germany.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.4.6.3. Germany: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.4.7. Lice Treatment Market - Italy
8.4.7.1. Italy: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.4.7.2. Italy.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.4.7.3. Italy: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.4.8. Lice Treatment Market - Spain
8.4.8.1. Spain: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.4.8.2. Spain.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.4.8.3. Spain: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.4.9. Lice Treatment Market - Netherlands
8.4.9.1. Netherlands: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.4.9.2. Netherlands.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.4.9.3. Netherlands: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.4.10. Lice Treatment Market - Russia
8.4.10.1. Russia: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.4.10.2. Russia.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.4.10.3. Russia: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.5. Lice Treatment Market - Asia Pacific
8.5.1. Asia Pacific: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.5.2. Asia Pacific.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.5.3. Asia Pacific: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.5.4. Lice Treatment Market - China
8.5.4.1. China: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.5.4.2. China.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.5.4.3. China: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.5.5. Lice Treatment Market - India
8.5.5.1. India: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.5.5.2. India.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.5.5.3. India: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.5.6. Lice Treatment Market - Malaysia
8.5.6.1. Malaysia: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.5.6.2. Malaysia.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.5.6.3. Malaysia: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.5.7. Lice Treatment Market - Japan
8.5.7.1. Japan: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.5.7.2. Japan.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.5.7.3. Japan: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.5.8. Lice Treatment Market - Indonesia
8.5.8.1. Indonesia: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.5.8.2. Indonesia.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.5.8.3. Indonesia: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.5.9. Lice Treatment Market - South Korea
8.5.9.1. South Korea: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.5.9.2. South Korea.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.5.9.3. South Korea: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.6. Lice Treatment Market - Middle East & Africa
8.6.1. Middle East & Africa: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.6.2. Middle East & Africa.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.6.3. Middle East & Africa: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.6.4. Lice Treatment Market - Saudi Arabia
8.6.4.1. Saudi Arabia: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.6.4.2. Saudi Arabia.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.6.4.3. Saudi Arabia: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.6.5. Lice Treatment Market - UAE
8.6.5.1. UAE: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.6.5.2. UAE.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.6.5.3. UAE: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.6.6. Lice Treatment Market - Israel
8.6.6.1. Israel: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.6.6.2. Israel.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.6.6.3. Israel: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.6.7. Lice Treatment Market - South Africa
8.6.7.1. South Africa: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.6.7.2. South Africa.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.6.7.3. South Africa: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.7. Lice Treatment Market - Latin America
8.7.1. Latin America: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.7.2. Latin America.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.7.3. Latin America: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.7.4. Lice Treatment Market - Mexico
8.7.4.1. Mexico: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.7.4.2. Mexico.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.7.4.3. Mexico: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.7.5. Lice Treatment Market - Brazil
8.7.5.1. Brazil: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.7.5.2. Brazil.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.7.5.3. Brazil: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
8.7.6. Lice Treatment Market - Argentina
8.7.6.1. Argentina: Lice Treatment Market, by Type, 2019-2032 (USD Million)
8.7.6.2. Argentina.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.7.6.3. Argentina: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Arbor Pharmaceuticals LLC (US)
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Bayer AG (Germany)
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Insight Pharmaceuticals (US)
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Omega Pharma NV (Belgium)
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Parasol Laboratories (US)
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Pfizer Inc. (US)
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Prestige Brands Holding Inc. (US)
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Sanofi SA (France)
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Sumitomo Chemical Co. Ltd. (Japan)
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. TAA Industries (Australia)
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. TecLabs Inc. (US)
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
10.12. Tyratech Inc. (US)
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Development
°ü·ÃÀÚ·á